Newsletter

Newsletter

Magnesium supplements reduces glucose insulin triglycerides in prediabetic men and women

Magnesium supplementation reduces glucose, insulin resistance, triglycerides in prediabetic men and women

Life Extension Update

Tuesday, May 19, 2015. On April 27, 2015, the journal Diabetes & Metabolism reported the outcome of a trial of men and women with low magnesium levels and prediabetes which found an improvement in glycemic status among those who received magnesium.

The study included 116 participants between the ages of 30 to 65 years with newly diagnosed prediabetes and serum magnesium levels of 1.8 milligrams per deciliter (mg/dL) or less. Subjects were advised to follow dietary and physical activity guidelines over the course of the study and were randomized to groups that received a magnesium chloride solution providing 382 mg magnesium or a control solution daily for four months. Fasting and two-hour post-load plasma glucose, serum magnesium and other factors were assessed at the beginning and end of the treatment period.

At the study's conclusion, fasting and post-load glucose levels, insulin resistance and triglycerides had significantly decreased among those who received magnesium, and an increase was observed in magnesium levels and high density lipoprotein (HDL) cholesterol levels.

"The percentage of subjects who improved their prediabetic state was significantly larger among those taking magnesium chloride compared with those in the control group, whereas unfavorable changes in prediabetic state were significantly higher in the controls than in those taking magnesium," authors Martha Rodriguez-Morán and colleagues report. "Our results support the hypothesis that, as a complement to lifestyle interventional programs, people with prediabetes and hypomagnesemia also should take magnesium supplements to decrease plasma glucose levels and potentially reduce the transition rate from prediabetes to diabetes. In this regard, given that measurement of serum magnesium is easy and accessible, the potential benefits of magnesium supplementation could readily be achieved in clinical settings."

 
What's Hot
Higher magnesium levels linked to lower risk of stroke
What's Hot  
 

August 20 2014. Findings derived from the Nurses' Health Study suggest a protective effect for magnesium against the risk of ischemic stroke in women.

The study, described online on August 12, 2014 in the American Heart Association journal Stroke, included 459 Nurses' Health Study participants who experienced an ischemic stroke prior to June 2006 and an equal number of control subjects matched for age, ethnicity and other factors. Blood samples collected between 1989 and 1990 were analyzed for plasma magnesium.

Subjects whose magnesium levels were among the lowest fifth of participants had a risk of stroke that was 34% higher than those whose levels were among the top fifth. Those whose levels were lower than 0.82 micromoles per liter had a 57% greater risk of total ischemic stroke, and a 66% higher risk of thrombotic stroke than women who had higher levels.

To authors Sally N. Akarolo-Anthony and her associates' knowledge, the association between magnesium levels and ischemic stroke risk has been evaluated in only one other prospective study. They remark that although only 1% of the body's magnesium exists in plasma, levels are strongly correlated with intracellular magnesium and could be a better indicator of the mineral's status than dietary intake. They note that risk factors for stroke, including diabetes and hypertension, have been associated with reduced magnesium levels, and that there is evidence that magnesium could help protect against blood clot formation.

"The results of this study suggest that low plasma magnesium may be associated with increased risk of ischemic stroke," the authors conclude. "If confirmed, our findings may have significant public health impact because magnesium deficiency is potentially modifiable."

 
Life Extension Clinical Research Update
Life Extension Clinical Research Update  
 

Coffee in Cognitive, Metabolic and Immune Health

Clinical trial to assess the effects of coffee in support of cognitive, metabolic and immune health in individuals with subjective memory complaints.

Compensation:

  • Study Product (organic coffee) and Supplies (e.g., French press and thermos)
  • Blood Tests (including specific immune markers associated with cognitive health)
  • Clinical Evaluations
  • Up to $200 for Time and Travel Expenses
  • $100 Gift Card toward Purchases from the Life Extension Foundation Buyers Club

Referral Bonus: $50.00
View Clinical Trial Details
Or Call For Details: 1-866-517-4536

Register Now

https://www.lifeextension.com/clinicalresearch/ClinicalTrials.htm

Health Concern

Diabetes

The most common clinical tests used to diagnose diabetes are measures of blood glucose. The fasting plasma glucose (FPG) test measures the amount of glucose in the blood after fasting. Prediabetes is diagnosed if the fasting blood glucose level is between 100 and 125 mg/dL. Diabetes is diagnosed if the fasting blood glucose level rises to 126 mg/dL or above.

The oral glucose tolerance test (OGTT) is used to measure insulin response to high glucose levels. During this test, patients are given glucose, and the rise in blood glucose levels is measured. Prediabetes is diagnosed if the glucose level rises to between 140 and 199 mg/dL. Diabetes is diagnosed if blood glucose levels rise to 200 mg/dL or higher.

The HbA1c test is also helpful in diagnosing less severe cases of diabetes. From this test, clinicians can estimate the average blood glucose level during the preceding two to four months. Normally 4 to 6 percent of hemoglobin is glycosylated, which corresponds to average blood glucose between 60 and 120 mg/dL. Mild hyperglycemia increases HbA1c to 8 to 10 percent (or 180 to 240 mg/dL), while severe hyperglycemia increases HbA1c values up to 20 percent. For diabetics, a healthy HbA1c level is less than 7 percent, which corresponds to an average blood glucose level of 150 mg/dL or less.

Read More
 
Latest Products
Disease Prevention and Treatment, 5th Edition

Disease Prevention and Treatment, 5th Edition

Item #DPT05
Learn More

Stay healthier longer with the hardcover or digital version of Disease Prevention and Treatment (5th ed). It's your ultimate medical reference guide, backed by nearly 17,000 references to the scientific literature.

Imagine, over 1,400 pages of breakthrough information that bridges the gap between cutting-edge science and mainstream medicine. This is information you simply won't find anywhere else, published by an organization passionate about keeping you younger and healthier longer.

Within Disease Prevention and Treatment, you'll find the latest evidence-based protocols for managing 130 different health concerns - from cancer and cardiovascular disease to arthritis and neurological disorders.

Daily C+ Effervescent Drink Mix, 30 packets

Daily C+ Effervescent Drink Mix, 30 packets

Item #01912
Add to Cart

Daily C+ is a delicious citrus flavored effervescent drink mix that provides the antioxidant power of 1,000 mg vitamin C blended with electrolytes and other essential nutrients, including vitamin D3, B vitamins and zinc.

Unlike other vitamin C drink mix products, Daily C +:

  • Contains bioactive B-vitamins - vitamin B2 (riboflavin 5'-phosphate), vitamin B6 (pyridoxal 5'-phosphate) and vitamin B12 (methylcobalamin)
  • Contains all non-GMO ingredients
  • Is low calorie (just 15 calories per packet)
  • Is sugar-free — because it is naturally sweetened with stevia and monk fruit extract
  • Is sodium-free

Daily C+ is ideal to take "on the go" to support the immune system, replenish electrolytes and boost energy naturally.

 
Related Life Extension Magazine® Articles
Magnesium Deficiency May Be
Caused By Prescription Pills
Magnesium
The missing link to a healthy heart
Life Extension Magazine Life Extension Magazine